rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Aaron Rosenberg

Chief Financial Officer

Company insider

Files Form 4 as: Chief Financial Officer, BeOne Medicines.

Every Form 4 they filed

In numbers

Trades disclosed
18
Buys
0
Sells
3
Bought
$0
Sold
$1.4M
Companies
1
Companies where not an officer
0
First trade
9 Aug 2024
Last trade
3 Aug 2026
Last filed
5 Aug 2026

Companies traded

Where they are an officer
ONC BeOne MedicinesOfficer · Biotechnology · last 3 Aug 20260 buys · 3 sells

Activity over time

1 Jul 2025 – 1 Oct 2026
10Jul 25Nov 25Mar 26Jun 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
3 Aug 2026filed 5 Aug 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Sold$362K1,157 at $312.72filing
3 Aug 2026filed 5 Aug 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Sold$362K1,157 at $312.72filing
11 Jun 2026filed 15 Jun 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Code A—71,175 at $0.00filing
11 Jun 2026filed 15 Jun 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Sold$163K631 at $257.74filing
11 Jun 2026filed 15 Jun 2026ONC BeOne Medicinesoption or derivative · BiotechnologySEC FORM 4 Code A—137,865 at $0.00filing
11 Jun 2026filed 15 Jun 2026ONC BeOne Medicinesoption or derivative · BiotechnologySEC FORM 4 Code A—137,865 at $0.00filing
11 Jun 2026filed 15 Jun 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Code A—71,175 at $0.00filing
11 Jun 2026filed 15 Jun 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Sold$163K631 at $257.74filing
6 Mar 2026filed 10 Mar 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Code A—79,014 at $0.00filing
6 Mar 2026filed 10 Mar 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Code A—40,573 at $0.00filing
6 Mar 2026filed 10 Mar 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Code A—79,014 at $0.00filing
6 Mar 2026filed 10 Mar 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Code A—40,573 at $0.00filing
1 Aug 2025filed 5 Aug 2025ONC BeOne MedicinesBiotechnologySEC FORM 4 Sold$346K1,190 at $290.47filing
10 Jun 2025filed 12 Jun 2025ONC BeOne Medicinesoption or derivative · BiotechnologySEC FORM 4 Code A—119,873 at $0.00filing
10 Jun 2025filed 12 Jun 2025ONC BeOne MedicinesBiotechnologySEC FORM 4 Code A—63,674 at $0.00filing
5 Mar 2025filed 7 Mar 2025ONC BeOne MedicinesBiotechnologySEC FORM 4 Code A—48,581 at $0.00filing
9 Aug 2024filed 13 Aug 2024ONC BeOne Medicinesoption or derivative · BiotechnologySEC FORM 4 Code A—220,987 at $0.00filing
9 Aug 2024filed 13 Aug 2024ONC BeOne MedicinesBiotechnologySEC FORM 4 Code A—118,547 at $0.00filing

News

Contrasting PainReform (NASDAQ:PRFX) & BeOne Medicines (NASDAQ:ONC)ONC · tickerreport.com · 21 Oct 2026

0 headlines in the last 90 days name Aaron Rosenberg; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care3

Buys in green, sells in red, by the company’s sector.

Related people

Xiaodong WangDirector and Other role · Director and Other at BeOne Medicines, filing Form 4 there in the last year
Chan Henry LeeSVP, General Counsel · SVP, General Counsel at BeOne Medicines, filing Form 4 there in the last year
BAKER BROS. ADVISORS LPDirector and 10% owner · Director at BeOne Medicines, filing Form 4 there in the last year
Titus B. BallPrincipal Accounting Officer · Principal Accounting Officer at BeOne Medicines, filing Form 4 there in the last year
Xiaobin WuPresident and COO · President and COO at BeOne Medicines, filing Form 4 there in the last year
John OylerChief Executive Officer · Also traded ONC in the last 90 days